Astellas Pharma Market Cap

Astellas Pharma has a market cap or net worth of $16.39 billion as of May 13, 2025. Its market cap has decreased by -2.49% in one year.

Market Cap

16.39B

Enterprise Value

20.74B

Revenue

12.77B

Ranking

n/a

PE Ratio

48.36

Stock Price

$9.27

Market Cap Chart

Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 16.39B, an increase of 135.40%. That is a compound annual growth rate of 2.60%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	16.58B	-5.11%
Dec 30, 2024	17.48B	-18.50%
Dec 29, 2023	21.44B	-22.67%
Dec 30, 2022	27.73B	-7.87%
Dec 30, 2021	30.10B	5.02%
Dec 30, 2020	28.66B	-10.92%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	729.62M
Tian'an Technology Group	568.98M
CytoDyn	497.14M
Glass House Brands	478.11M
Elite Pharmaceuticals	468.54M
Northwest Biotherapeutics	395.18M

Market Cap Rankings